Shoulder Innovations (SI) Cash & Equivalents (2024 - 2026)

Shoulder Innovations has reported Cash & Equivalents for 3 years, with the latest figure at $11.5 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents changed N/A year-over-year to $11.5 million; the trailing twelve-month figure through Mar 2026 stood at $11.5 million (changed N/A YoY), and the FY2025 full-year result was $26.9 million, up 338.85% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $11.5 million, down from $26.9 million in the prior quarter.
• The five-year high for Cash & Equivalents was $54.9 million in Q3 2025, with the low at $6.1 million in Q4 2024.
• Historically, Cash & Equivalents has averaged $25.3 million across 3 years, with a median of $26.9 million in 2025.
• The largest YoY upside for Cash & Equivalents was 338.85% in 2025 against a maximum downside of 338.85% in 2025.
• Shoulder Innovations' Cash & Equivalents stood at $6.1 million in 2024, then soared by 338.85% to $26.9 million in 2025, then plunged by 57.23% to $11.5 million in 2026.
• The last three Cash & Equivalents figures came in at $11.5 million (Q1 2026), $26.9 million (Q4 2025), and $54.9 million (Q3 2025), per Business Quant data.